Concepedia

Publication | Open Access

OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer

220

Citations

16

References

2018

Year

Abstract

Clinical trials.gov identifier: NCT02258659.

References

YearCitations

Page 1